Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 64 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Have a BMI within range 30.0 to 40.0kg/m2, inclusive.
Females who meet above criteria must be physiologically incapable of becoming pregnant (ie., surgically sterilized, or post-menopausal per protocol definition).
History of eating disorders.
Recent history of weight loss or gain.
Had gastrointestinal surgery for treatment of obesity.
Type 1 or type 2 diabetes mellitus.
Have a positive urine drug screen.
Have liver disease.
Have hepatitis B, hepatitis C, or HIV antibodies.
Have a thyroid disorder that is not under control with medication.
Have any disease (such as heart, liver, blood, nervous system, or kidney disease, or cancer).
Are unable to participate in an exercise program.
Have used weight loss drugs within 3 months before the start of the study.
Are currently using warfarin, digoxin, oral anti-coagulants (other than aspirin and non-steroidal anti-inflammatory drugs), oral or injectable corticosteroids (inhaled & intranasal corticosteroids are permitted), or antiretroviral medications.
Used of any investigational drug or device during the study or within 30 days prior to 1st dosing of study medication.